Pliant Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
PLRX
CUSIP
729139105
Type
Equity
Class
COM
Num filings
155
Total reported value, excl. options
$1.53 B
Manager Report Date Value ($000) Shares Option Type